Status:
COMPLETED
Helicobacter Pylori Eradication After Endoscopic Resection of Gastric Tumors
Lead Sponsor:
Seoul National University Hospital
Conditions:
Gastric Tumor
Helicobacter Pylori
Eligibility:
All Genders
20-75 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether Helicobacter pylori eradication could reduce the new tumor development after endoscopic resection of gastric tumor.
Detailed Description
The association between Helicobacter pylori infection and development of gastric cancer has been established by epidemiologic studies. Conversely, eradication of H. pylori showed no significant reduct...
Eligibility Criteria
Inclusion
- H pylori infected patients with gastric low-grade dysplasia, high-grade dysplasia, and early gastric cancer
- Gastric tumor is completely removed through endoscopic resection.
Exclusion
- Patients underwent gastrectomy before enrollment
- patients underwent endoscopic resection before enrollment
- Previous history of eradication for H. pylori
- Pregnancy
- Aged \<20 yr old or aged \>75 yr old
- Patients underwent additional gastrectomy due to incomplete endoscopic resection
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
855 Patients enrolled
Trial Details
Trial ID
NCT01510730
Start Date
January 1 2005
End Date
February 1 2011
Last Update
March 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital
Seoul, Seoul, South Korea, 110-744